Astec LifeSciences Limited has informed the Exchange about General Updates regarding filing of it Business Responsibility and Sustainability Report
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25 to BSE and NSE, a SEBI-mandated annual ESG disclosure. The company, a 100% agrochemicals manufacturer (fungicides, insecticides and intermediates) under the Godrej group, reported turnover of around ₹381 crore and net worth of ₹234 crore for the year. Exports account for 68.4% of revenue across 18 countries. The company has committed to Science Based Targets — a 37.5% cut in Scope 1 & 2 emissions, 16% cut in Scope 3, and Net Zero for Scope 1 & 2 by FY 2034-35, along with a target of 80% renewable energy use. There were no cases of bribery, corruption, fines, or pending shareholder complaints during the year. One point worth noting: R&D spend specifically aimed at improving environmental or social impact of products dropped from 13.1% in FY24 to 0% in FY25.
This is a routine annual ESG compliance filing and is unlikely to move the stock price on its own. However, it gives investors a clear view of the company's sustainability commitments, strong export orientation, and clean governance record, which are broadly positive signals for long-term investors.